MALVERN, Pa. (AP) — Shares of wireless medical device maker BioTelemetry jumped Monday after the company announced it had prevailed in court — and subsequently acquired — a rival wireless technology company. The maker of remote heart monitors said it won a key victory in a patent dispute over its technology with Mednet Healthcare Technologies. Mednet and its subsidiaries entered a consent judgment, declaring that they had infringed five patents owned by Biotelemetry . Following the judgment, Biotelemetry acquired all outstanding shares of its Melville, N.Y. -based rival for $6.3 million in cash and stock and the assumption of $9.7 million in debt. "I believe the acquisition of Mednet is the best possible outcome for all involved," said Biotelemetry CEO Joseph Capper , in a statement. "While an unorthodox path to such a combination, the company will benefit from Mednet's more than $25 million in annual revenue." Shares of BioTelemetry Inc. rose $1.61 , or 22 percent, to $8.90 .
Most Popular Stories
- Koch Brothers Step up Anti-Obamacare Campaign
- FDIC Sues Big Banks Over Rate Manipulation
- Vybz Kartel Convicted of Murder
- Is Malaysian Airlines Flight 370 in Andaman Sea?
- SoCalGas Reaches Record Spend on Diversity Suppliers
- FDIC Accuses Big Banks of Fraud, Conspiracy
- Stocks Close Lower Ahead of Crimea Vote
- U.S. Consumer Sentiment Falls in Early March
- Ulta Shares Look Good on Strong Q4
- Jittery Investors Dumping Russian Stocks